Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPINASTINE OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/138826
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition for topical administration, which contains epinastine or a salt thereof as an active ingredient at a concentration of 0.05 to 1% (w/w) and which enables long-term retention of the active ingredient concentration in eye tissue even when the dose is a low concentration.

Inventors:
OGURA NAOKI (JP)
KAJIWARA YU (JP)
FUJISAWA KOUSHI (JP)
ESAKI YOSHIHIKO (JP)
SAKANAKA KOJI (JP)
FUJISAWA TOYOMI (JP)
TONE YUKO (JP)
Application Number:
PCT/JP2021/047886
Publication Date:
June 30, 2022
Filing Date:
December 23, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/551; A61K9/06; A61K9/107; A61K47/06; A61K47/10; A61K47/12; A61K47/14; A61K47/44; A61P27/02; A61P27/14; A61P37/08
Domestic Patent References:
WO2004064817A12004-08-05
WO2007007851A12007-01-18
Foreign References:
JP2005053907A2005-03-03
JP2007530481A2007-11-01
JP2006522053A2006-09-28
JP2009500397A2009-01-08
JP2010502564A2010-01-28
JP2020019767A2020-02-06
JP2020055799A2020-04-09
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: